Healthium Medtech has entered into an exclusive deal with U.S.-firm Tisgenx to distribute bovine pericardial tissue patches in India. These patches are used in critical heart valve repairs and vessel reconstructions elevating India’s cardiac surgery toolkit with surgeon-trusted global solutions.
Glimpse:
Healthium Medtech has signed an exclusive partnership with Tisgenx, a U.S. company that manufactures high-quality bovine pericardial tissue patches, now made available for Indian surgeons. These tissue patches are commonly used in heart valve repairs, vessel reconstruction, and other complex cardiovascular and soft-tissue procedures. Under the agreement, Healthium will distribute Tisgenx’s products across India, leveraging its wide clinical distribution network. The collaboration strengthens Healthium’s cardiac care segment, enabling access to proven surgical tools and enhancing its innovation-led, surgeon-centric portfolio. Both CEOs expressed that this move aligns with growing demand in India’s cardiac surgical space and underscores Healthium’s commitment to specialty-driven offerings.
India’s medtech landscape just got a stronger rhythm. Healthium Medtech, already known for its strong surgical, wound care, and infection prevention portfolios, has made a strategic leap forward by partnering exclusively with Tisgenx, Inc. to distribute bovine pericardial tissue patches across India.
Why this matters: pericardial tissue patches are critical in cardiac surgeries think valve repair, vessel reconstruction, and difficult soft tissue work. Surgeons performing such procedures often require material that is reliable, durable, and biocompatible. Before this deal, sourcing such tissue patches involved import delays, variable pricing, and sometimes limited availability.
With Healthium as the exclusive distributor, Indian cardiac surgical centers will have more reliable access to these patches. Healthium’s existing distribution network, clinical relationships, and local manufacturing ethos make them well-placed to integrate these high performance patches into routine practice. By expanding its cardiac care portfolio, Healthium is moving beyond consumables and wound care, deeper into high-precision specialty solutions.
From Healthium’s side, the move also reflects an innovation-led strategy: combining global surgical standards with solutions tailored for Indian anatomy, procurement constraints, and clinical workflows. It’s a message that medtech in India is not just about cost-effectiveness it’s about quality, trust, and enabling surgeons to work with best-in-class tools.
CEO Anish Bafna of Healthium emphasized surgeon-centric innovation, saying that bringing Tisgenx’s patches to India isn’t just adding another product it’s adding solutions that respect clinical precision, patient safety, and outcome reliability. Tisgenx’s CEO added that India is a key strategic market, and working with Healthium will help bring global innovation closer to Indian ORs.
Of course, challenges will persist: ensuring quality maintenance through the supply chain, regulatory approvals and certifications, cost management for hospitals and patients, and training surgeons about the optimal usage patterns for these patches. But overall, the partnership looks like a win-win: global technology meeting local needs.
“With this exclusive partnership, we are proud to bring globally proven tissue patch technologies into Indian cardiac surgery, making high-precision solutions more accessible and dependable for surgeons and patients alike,”
By
HB Team
